Latest Headlines

Latest Headlines

Sanofi taps Adimab for antibody R&D

Sanofi inked a deal with the antibody discovery experts at Adimab, partnering up to generate a fleet of potential medicines.

Serum Institute gets Genticel's Vaxiclase tech to develop pertussis vaccine

With recent news of clinical trials for its low-cost HPV vaccine, the Serum Institute has already made waves in the world of Big Pharma. The India-based vaccinemaker is now gearing up to challenge the world's leading vaccinemakers in another area: pertussis.

3M seeking pharma licensing partner for its microneedle delivery devices

3M pronounced last week that its Hollow Microstructure Transdermal System for home drug delivery by patients is available for licensing at the Drug Delivery Partnerships conference in Boca Raton, FL.

Astellas joins forces with Immunomics on allergy vaccine

Astellas Pharma is getting a piece of the vaccine pie. The Japanese company is joining forces with U.S.-based Immunomic Therapeutics to develop the latter's vaccine to treat allergies caused by Japanese red cedar.

Ortho-Clinical and Quotient strike $69M deal for blood transfusion test

Ortho-Clinical Diagnostics has signed an exclusive deal worth up to $69 million with commercial-stage company Quotient to distribute and sell a blood transfusion diagnostics platform in development.

T2 Biosystems scores $8.5M deal with Canon U.S. Life Sciences to develop Lyme disease test

T2 Biosystems inked an $8.5 million deal with Canon U.S. Life Sciences to develop a rapid diagnostic test for Lyme disease, expanding its offerings and looking to carve a niche in a growing market.

MannKind and Sanofi launch inhaled insulin in U.S.

After suffering from unflattering comparisons to Pfizer's infamous inhaled insulin flop Exubera at a cost of $2.8 billion, two FDA rejections, and mockery over its long-running promise to find a marketing partner, Mannkind today announced that its fast-acting Afrezza inhaled insulin is available at U.S. pharmacies.

Medtronic partners with LHC to provide at-home, post-acute care patient monitoring services

Medtronic has partnered to provide patient monitoring to home health, hospice and comprehensive post-acute healthcare services LHC Group. The deal was done through its Cardiocom business, which already serves four out of the 5 largest U.S. home healthcare organizations.

Mylan buys into Theravance's COPD contender in $265M deal

Generics giant Mylan is shouldering its way into the blockbuster market for COPD treatments, signing a $265 million deal with the respiratory experts at Theravance Biopharma to get its hands on a late-stage contender.

Post-merger Simbec-Orion inks two Phase III deals

Welsh CRO Simbec-Orion has agreed to run two late-stage trials, deals the company says affirm the strategy behind its 2014 merger.